Dr. Ashwin Blake Karanam, MD, MPH

Dr. Karanam practices at Temple University Hospital - Main Campus in Philadelphia, Pennsylvania.

Dr. Karanam's NPI, 1083107825, was assigned on June 6, 2018. Dr. Karanam graduated from Rutgers New Jersey Medical School in 2018. Dr. Karanam holds Pennsylvania license MD483721.

Dr. Karanam's primary practice is Temple University Hospital - Main Campus, at 3401-41 N Broad St, Philadelphia, PA 19140 in Philadelphia County. The practice phone is (215) 707-5303.

Dr. Karanam's primary practice is Temple University Hospital - Main Campus in Philadelphia, Pennsylvania. Dr. Karanam is also affiliated with Temple University Hospital. The medical group on file is Temple Faculty Physicians. Dmand AI also links Dr. Karanam to 1 more hospital, named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Karanam practices, 2 sites in all. Vendor and product names are available with a free account.

Pulmonary disease is Dr. Karanam's primary specialty in the NPI Registry, under taxonomy code 207RP1001X. Dr. Karanam is licensed in Pennsylvania.

CMS data shows 223 Medicare services from Dr. Karanam across 8 procedure codes in 2024, for 144 Medicare patients. Medicare paid $17,331 for them. Every service was in a facility, such as a hospital, rather than an office.

CMS counts 144 Medicare patients who saw Dr. Karanam in 2024. The largest group is 65 to 74, with 79 patients. 75% of them have high blood pressure, and 75% have high cholesterol. 38% are also on Medicaid. Their average risk score is 2.67, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Karanam's median patient age at 68, with 50% women.

In 2024, Dr. Karanam wrote 249 Medicare Part D claims for 43 patients. 28% of them were for generic drugs. CMS names the drug for 179 of them, across 7 drugs with 11 or more claims each, at $109,812 in total drug cost. In 2023, CMS named 105 claims across 5 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 81 out of 100 for Dr. Karanam for performance year 2024, reported as part of a group. Dr. Karanam accepts Medicare assignment, so Medicare's approved amount is taken as full payment.

Dmand AI links 13 papers to Dr. Karanam, published from 2015 to 2025. 2016 was the busiest year, with 3. The most frequent topics are Anticonvulsants, Epilepsy and Lamotrigine. Dr. Karanam has published most often in Pharmacotherapy. Dr. Karanam's most frequent co-authors are Page B. Pennell, MD, Mark Joseph Russo, MD, MS and Dhaval Chauhan, MD.

CMS Open Payments shows 6 general payments to Dr. Karanam from 5 drug and device companies from 2021 to 2025. Food and beverage make up the largest share, 100% of the total. Boehringer Ingelheim Pharmaceuticals, Inc. paid the most, $146.

Dr. Karanam graduated from Rutgers New Jersey Medical School in 2018.